WuXi Biologics Partners with Pharmadule Morimatsu AB for CRDMO Expansion in Singapore
China-based WuXi Biologics (HKG: 2269) has announced a strategic partnership with Sweden-headquartered Pharmadule Morimatsu AB...
Deals
Mega Lifesciences Secures Exclusive Rights for Bio-Thera’s Bevacizumab Biosimilar in Indonesia
Thailand-based Mega Lifesciences (BKK: MEGA) has announced an in-licensing agreement with China-based Bio-Thera Solutions (SHA:...
Sinopharm Expands Partnership with Guizhou Government to Boost Health Industry
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strengthened partnership with the...
Coherent Biopharma and C-Ray Therapeutics Partner to Advance Peptide-Drug Conjugate Development
China-based Coherent Biopharma and C-Ray Therapeutics have announced a strategic partnership to delve into the...
Shionogi’s Acquisition of Qpex Impacts Brii Biosciences’ Rights to Anti-infective Drugs
Japan’s Shionogi & Co., Ltd (TYO: 4507) announced on June 26, 2023, its planned acquisition...
Innovent Biologics and RemeGen Partner on Clinical Study for PD-1 Inhibitor and ADC Drugs
China-based Innovent Biologics Inc., (HKG: 1801) has entered into a clinical study and supply cooperation...
Kite Pharma’s Yescarta Marketing Rights Transferred to Gilead Sciences K.K. in Japan
US immunotherapy specialist Kite Pharma, Inc. has announced that the Marketing Authorization for Yescarta (axicabtagene...
Edding Pharma Aims for Fifth IPO Attempt on Hong Kong Stock Exchange
China-based Edding Pharma is gearing up for its fifth attempt to hold an initial public...
Aureka Biotechnologies Secures $10 Million in Seed Funding for AI-Driven Biotechnology
Aureka Biotechnologies Inc., a California-based artificial intelligence (AI)-empowered biotech company, has successfully raised USD 10...
Xiamen ITG Group and Fosun Health Collaborate on Big Health Industry Fund and Medical Device Commercialization
China-based Xiamen ITG Group Co., Ltd. (SHA: 600755) and Shanghai Fosun Health Technology (Group) Co.,...
Shanghai Cell Therapy Group Partners with Nantong Federation for Comprehensive Health Services Platform
Shanghai Cell Therapy Group has entered into a partnership with the Nantong Federation of Industry...
Huadong Medicine’s Subsidiary Perfect mRNA Biotechnology Partners with Yoltech Therapeutics
China-based Huadong Medicine Co., Ltd (SHE: 000963) subsidiary, Hangzhou Perfect mRNA Biotechnology Co., Ltd, has...
Novlead Biotech Secures RMB 100 Million in Series B+ Financing for Nitric Oxide Therapy Innovations
Novlead Biotech, a specialist in nitric oxide gas detection and treatment based in Nanjing, has...
Guangdong Zhongsheng Pharmaceutical Plans to Raise RMB 600 Million via Private Placement
China-based Guangdong Zhongsheng Pharmaceutical Co., Ltd (SHE: 002317) is poised to raise RMB 600 million...
United Imaging Healthcare Acquires Stake in Apactron for High-End Particle Therapy Technology
Shanghai-based United Imaging Healthcare (UIH, SHA: 688271) has announced an investment of RMB 45 million...
Sequanta Technologies Partners with DarkJade Sciences to Establish Organoid Bank and Glioma Project
Sequanta Technologies, a leading multi-omics research and clinical service provider based in Shanghai, has announced...
Insilico Medicine Partners with ShanghaiTech University for Tumor Drug R&D Advancement
China-based AI-powered drug discovery firm Insilico Medicine has struck a partnership with ShanghaiTech University’s iHuman...
Adicon Holdings Ltd IPO: A Strategic Move for Growth in Diagnostics
Adicon Holdings Ltd (HKG: 9860), a China-based independent clinic laboratory (ICL) service provider, has successfully...
Acotec Scientific Holdings and Boston Scientific Group plc Sign MOU to Broaden Collaboration
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced a memorandum of understanding (MoU) with...
Jiangsu Hengrui Medicine Cancels Licensing Agreement with Mabworks Citing Market Changes
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has announced its decision to cancel a...